Los puntos clave no están disponibles para este artículo en este momento.
Anakinra is the cheapest anti-IL-1 agent used in the treatment of colchicine-resistant FMF. It is shown to be effective and safe when used in adjunct to colchicine however its short half-life and potential to cause injection site reactions limit its use.
Parlar et al. (Fri,) studied this question.